Zuo‐Lin Li

The hypoxia response pathway promotes PEP carboxykinase and gluconeogenesis in C. elegans

The role of inflammasomes in kidney disease

Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities

Inflammation and tumor progression: signaling pathways and targeted intervention

Pyroptosis: mechanisms and diseases

Broadening horizons: the role of ferroptosis in cancer

Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery

Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles

The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation

Hypoxia-inducible factor induces cysteine dioxygenase and promotes cysteine homeostasis in Caenorhabditis elegans

Lipid-Based Nanovesicular Drug Delivery Systems

Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer

The biology , function , and biomedical applications of exosomes

Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy

Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation

Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis

Therapeutic application of extracellular vesicles in kidney disease: promises and challenges

Kim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI

Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients